📰 Andreaf Wainer News
Page 5 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
May 1, 2024
ICW Investment Advisors LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 27,980 shares of the healthcare product maker’s stock after buying an additional 162 shares during the quarter. […]
April 30, 2024
Cary Street Partners Investment Advisory LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 69.8% in the fourth quarter, Holdings Channel reports. The firm owned 15,360 shares of the healthcare product maker’s stock after selling 35,555 shares during the period. Cary Street Partners Investment Advisory LLC’s holdings in Abbott Laboratories […]
April 30, 2024
Cary Street Partners Investment Advisory LLC cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 69.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,360 shares of the healthcare product maker’s stock after selling 35,555 shares during the quarter. […]
April 30, 2024
Norden Group LLC lowered its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 13.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,424 shares of the healthcare product maker’s stock after selling 3,053 shares during the quarter. Abbott Laboratories makes […]
April 30, 2024
Cary Street Partners Investment Advisory LLC cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 69.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,360 shares of the healthcare product maker’s stock after selling 35,555 shares during the quarter. […]
April 29, 2024
Blue Chip Partners LLC decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 145,424 shares of the healthcare product maker’s stock after selling 6,636 shares during the quarter. Abbott […]
April 29, 2024
Argyle Capital Management Inc. decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 32.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,615 shares of the healthcare product maker’s stock after selling 3,150 shares during the period. Argyle Capital […]
April 29, 2024
Silver Oak Securities Incorporated boosted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 125.2% during the fourth quarter, Holdings Channel.com reports. The fund owned 7,816 shares of the healthcare product maker’s stock after acquiring an additional 4,346 shares during the period. Silver Oak Securities Incorporated’s holdings in Abbott Laboratories were worth $860,000 at […]
April 29, 2024
Legacy Capital Wealth Partners LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 5,616 shares of the healthcare product maker’s stock, valued at approximately $618,000. A number of other institutional investors […]
April 28, 2024
Cornerstone Capital Inc. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 4.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 241,640 shares of the healthcare product maker’s stock after selling 11,176 shares during the quarter. Abbott Laboratories comprises about 2.9% of Cornerstone Capital Inc.’s holdings, making the stock its […]